JNK/PI3K/Akt signaling pathway is involved in myocardial ischemia/reperfusion injury in diabetic rats: Effects of salvianolic acid A intervention

American Journal of Translational Research

Volumn 8, Issue 6, 2016, Pages 2534-2548

  Chen, Qiuping ^a   Xu, Tongda ^a   Li, Dongye ^a   Pan, Defeng ^a   Wu, Pei ^a   Luo, Yuanyuan ^a   Ma, Yanfeng ^a   Liu, Yang ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic rats; Ischemia reperfusion; JNK; PI3K Akt signaling pathway; Sal A

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BENZOFURAN DERIVATIVE; CASPASE 3; LACTATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SALVIANOLIC ACID A; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART RATE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TUNEL ASSAY; WESTERN BLOTTING;

EID: 84976407225     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O’Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P. Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85-151.
2. Hotta H, Miura T, Miki T, Togashi N, Maeda T, Kim SJ, Tanno M, Yano T, Kuno A, Itoh T, Satoh T, Terashima Y, Ishikawa S, Shimamoto K. Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts. Circ Res 2010; 106: 129-132.
3. Lee MG, Jeong MH, Ahn Y, Chae SC, Hur SH, Hong TJ, Kim YJ, Seong IW, Chae JK, Rhew JY, Chae IH, Cho MC, Bae JH, Rha SW, Kim CJ, Choi D, Jang YS, Yoon J, Chung WS, Cho JG, Seung KB, Park SJ, Other Korea Acute Myocardial Infarction Registry Investigators. Comparison of clinical outcomes following acute myocardial infarctions in hypertensive patients with or without diabetes. Korean Circ J 2009; 39: 243-250.
4. Li H, Liu Z, Wang J, Wong GT, Cheung CW, Zhang L, Chen C, Xia Z, Irwin MG. Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats. Cardiovasc Diabetol 2013; 12: 133.
5. Hess K, Marx N, Lehrke M. Cardiovascular disease and diabetes: the vulnerable patient. Eur Heart J Suppl 2012; 14: B4-B13.
6. Fang F, Li D, Pan H, Chen D, Qi L, Zhang R, Sun H. Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through the PI3K/Akt pathway in simulated ischemia/reperfusion. Pharmacology 2011; 88: 149-158.
7. Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT, Botker HE, Flyvbjerg A. Ischaemic preconditioning does not protect the heart in obese and lean animal models of Type 2 diabetes. Diabetologia 2004; 47: 1716-1721.
8. Ghaboura N, Tamareille S, Ducluzeau PH, Grimaud L, Loufrani L, Croue A, Tourmen Y, Henrion D, Furber A, Prunier F. Diabetes mellitus abrogates erythropoietin-induced cardio-protection against ischemic-reperfusion injury by alteration of the RISK/GSK-3beta signaling. Basic Res Cardiol 2011; 106: 147-162.
9. Song T, Lv LY, Xu J, Tian Z, Cui W, Wang Q, Qu G, Shi X. Diet-induced obesity suppresses sevoflurane preconditioning against myocardial ischemia-reperfusion injury: role of AMP-activated protein kinase pathway. Exp Biol Med 2011; 236: 1427-1436.
10. Yu QJ, Gao F, Ma XL. Insulin says NO to cardiovascular disease. Cardiovasc Res 2011; 89: 516-524.
11. Li HL, Yu XC. Emerging role of JNK in insulin resistance. Curr Diabetes Rev 2013; 9: 422-428.
12. Zhang X, Xu A, Chung SK, Cresser JH, Sweeney G, Wong R, Lin A, Lam KS. Selective inactivation of c-Jun NH2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle in mice. Diabetes 2011; 60: 486-495.
13. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature 2002; 420: 333-6.
14. Taniguchi CM, Aleman JO, Ueki K, Luo J, Asano T, Kaneto H, Stephanopoulos G, Cantley LC, Kahn CR. The p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance. Mol Cell Biol 2007; 27: 2830-2840.
15. Shah SA, Lee HY, Bressan RA, Yun DJ, Kim MO. Novel osmotin attenuates glutamate-induced synaptic dysfunction and neurodegeneration via the JNK/PI3K/Akt pathway in postnatal rat brain. Cell Death Dis 2014; 5: e1026.
16. Qiao ZY, Ma JW, Liu HJ. Evaluation of the anti-oxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury. Molecules 2011; 16: 10002-10012.
17. Wang XJ, Wang ZB, Xu JX. Effect of salvianic acid A on lipid peroxidation and membrane permeability in mitochondria. J Ethnopharmacol 2005; 97: 441-445.
18. Zhang YQ, Tang Y, Wu AL, Zhu HB. Salvianolic acid A displays cardioprotective effects in in vitro models of heart hypoxia/reoxygenation injury. J Asian Nat Prod Res 2010; 12: 899-915.
19. Xu H, Li YL, Che X, Tian HC, Fan HY, Liu K. Metabolism of salvianolic acid A and antioxidant activities of its methylated metabolites. Drug Metab Dispos 2014; 42: 274-281.
20. Fan HY, Fu FH, Yang MY, Xu H, Zhang AH, Liu K. Antiplatelet and antithrombotic activities of salvianolic acid A. Thromb Res 2010; 126: e17-22.
21. Pan H, Li D, Fang F, Chen D, Qi L, Zhang R, Xu T, Sun H. Salvianolic acid A demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury. J Cardiovasc Pharmacol 2011; 58: 535-542.
22. Morrison LE, Whittaker RJ, Klepper RE, Wawrousek EF, Glembotski CC. Roles for alphaB-crystallin and HSPB2 in protecting the myocardium from ischemia-reperfusion -induced damage in a KO mouse model. Am J Physiol Heart Circ Physiol 2004; 286: H847-855.
23. Wu X, Xu TD, Li DY, Zhu SS, Chen QP, Hu WJ, Pan D, Zhu H, Sun H. ERK/PP1a/PLB/ SERCA2a and JNK pathways are involved in luteolin-mediated protection of rat hearts and cardiomyocytes following ischemia/reperfusion. PLoS One 2013; 8: e82957.
24. Qi LL, Pan HJ, Li DY, Fang F, Chen D, Sun H. Luteolin improves contractile function and at- tenuates apoptosis following ischemia-reperfusion in adult rat cardiomyocytes. Eur J Pharmacol 2011; 668: 201-207.
25. Bae SC, Zhang LB. Gender differences in cardioprotection against Ischemia/Reperfusion injury in adult rat hearts: Focus on Akt and protein kinase C signaling. J Pharmacol Exp Ther 2005; 315: 1125-1135.
26. Jones LR. Mg2+ and ATP effects on K+ activation of the Ca2+-transport ATPase of cardiac sarcoplasmic reticulum. Biochim Biophys Acta 1979; 557: 230-242.
27. Kodavanti PR, Cameron JA, Yallapragada PR, Desaiah D. Effect of chlordecone (Kepone) on calcium transport mechanisms in rat heart sarcoplasmic reticulum. Pharmacol Toxicol 1990; 67: 227-234.
28. Pande M, Cameron JA, Vig PJ, Desaiah D. Phencyclidine block of Ca2+ ATPase in rat heart sarcoplasmic reticulum. Toxicology 1998; 129: 95-102.
29. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reper-fusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004; 61: 448-460.
30. Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: A common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 2005; 15: 69-75.
31. Yin X, Zheng Y, Zhai XJ, Zhao X, Cai L. Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury. Exp Diabetes Res 2012; 2012: 198048.
32. Miki T, Miura T, Hotta H, Tanno M, Yano T, Sato T, Terashima Y, Takada A, Ishikawa S, Shimamoto K. Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition. Diabetes 2009; 58: 2863-2872.
33. Han MS, Jung DY, Morel C, Lakhani SA, Kim JK, Flavell RA, Davis RJ. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 2013; 339: 218-222.
34. Chambers JW, Pachori A, Howard S, Iqbal S, LoGrasso PV. Inhibition of JNK Mitochondrial Localization and Signaling Is Protective against Ischemia/Reperfusion Injury in Rats. J Biol Chem 2013; 288: 4000-4011.
35. Masharani UB, Maddux BA, Li XJ, Sakkas GK, Mulligan K, Schambelan M, Goldfine ID, Youngren JF. Insulin Resistance in Non-Obese Subjects Is Associated with Activation of the JNK Pathway and Impaired Insulin Signaling in Skeletal Muscle. PLoS One 2011; 6: e19878.
36. Jia N, Han K, Kong JJ, Zhang XM, Sha S, Ren GR, Cao YP. (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus. Mol Cell Biochem 2013; 380: 211-218.
37. Lovell MJ, Yasin M, Lee KL, Cheung KK, Shintani Y, Collino M, Sivarajah A, Leung KY, Takahashi K, Kapoor A, Yaqoob MM, Suzuki K, Lythgoe MF, Martin J, Munroe PB, Thiemermann C, Mathur A. Bone marrow mononuclear cells reduce myocardial reperfusion injury by activating the PI3K/Akt survival pathway. Atherosclerosis 2010; 213: 67-76.
38. Granata R, Trovato L, Gallo MP, Destefanis S, Settanni F, Scarlatti F, Brero A, Ramella R, Volante M, Isgaard J, Levi R, Papotti M, Alloatti G, Ghigo E. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart. Cardiovasc Res 2009; 83: 303-312.
39. Anwar A, Schluter KD, Heger J, Piper HM, Euler G. Enhanced SERCA2A expression improves contractile performance of ventricular cardiomyocytes of rat under adrenergic stimulation. Pflugers Arch 2008; 457: 485-491.
40. Chen Y, Zhao J, Du JB, Xu GH, Tang CS, Geng B. Hydrogen sulfide regulates cardiac sarcoplasmic reticulum Ca(2+) uptake via K(ATP) channel and PI3K/Akt pathway. Life Sci 2012; 91: 271-278.
41. Kralik PM, Ye G, Metreveli NS, Shem X, Epstein PN. Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes. Cardiovasc Toxicol 2005; 5: 285-292.
42. Zhang CM, Gao L, Zheng YJ, Yang HT. Berbamine protects the heart from ischemia/ reperfusion injury by maintaining cytosolic Ca(2+) homeostasis and preventing calpain activation. Circ J 2012; 76: 1993-2002.
43. Zhao ZQ, Vinten-Johansen J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res 2002; 55: 438-455.
44. Stephanou A, Scarabelli TM, Townsend PA, Bell R, Yellon D, Knight RA, Latchman DS. The carboxyl-terminal activation domain of the STAT-1 transcription factor enhances ischemia/reper-fusion-induced apoptosis in cardiac myocytes. FASEB J 2002; 16: 1841-1843.
45. Chae IH, Park KW, Kim HS, Oh BH. Nitric oxide-induced apoptosis is mediated by Bax/Bcl-2 gene expression, transition of cytochrome c, and activation of caspase-3 in rat vascular smooth muscle cells. Clin Chim Acta 2004; 341: 83-91.
46. Dong JW, Zhu HF, Zhu WZ, Ding HL, Ma TM, Zhou ZN. Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression. Cell Res 2003; 13: 385-391.
47. Shi C, Wu F, Yew DT, Xu J, Zhu Y. Bilobalide prevents apoptosis through activation of the PI3K/Akt pathway in SH-SY5Y cells. Apoptosis 2010; 15: 715-727.
48. Sun DD, Huang J, Zhang Z, Gao HK, Li JY, Shen M, Cao F, Wang H. Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PLoS One 2012; 7: e33491.